LEONI, VALERIO
LEONI, VALERIO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Biological variation of Serum Amyloid A in healthy subjects
2001 Melzi d’Eril, G; Anesi, A; Maggiore, M; Leoni, V
Glucose accelerates copper- and ceruloplasmin-induced oxidation of low-density lipoprotein and whole serum
2002 Leoni, V; Albertini, R; Passi, A; Abuja, P; Borroni, P; Melzi d’Eril GV and De Luca, G
Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis
2002 Leoni, V; Masterman, T; Diczfalusy, U; De Luca, G; Hillert, J; Björkhem, I
Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers
2003 Leoni, V; Masterman, T; Patel, P; Meane, Y; Diczfalusy, U; Björkhem, I
Diagnostic use of cerebral and extracerebral oxysterols
2004 Leoni, V; Masterman, T; Mousavi, F; Wretlind, B; Wahlund, L; Diczfalusy, U; Hillert, J; Björkhem, I
Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis
2005 Leoni, V; Lütjohann, D; Masterman, T
Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis
2006 Danylaitè Karrenbauer, V; Leoni, V; Lim, E; Giovannoni, G; Ingle, G; Sastre-Garriga, J; Thompson, A; Rashid, W; Davies, G; Miller, D; Björkhem, I; Masterman, T
Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?
2006 Leoni, V; Shafaati, M; Salomon, A; Kivipelto, M; Björkhem, I; Wahlund, L
Oxysterols and Alzheimer's disease
2006 Björkhem, I; Heverin, M; Leoni, V; Meaney, S; Diczfalusy, U
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
2007 Valenza, M; Carroll, J; Leoni, V; Bertram, L; Björkhem, I; Singaraja, R; Di Donato, S; Lutjohann, D; Hayden, M; Cattaneo, E
Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders
2007 Shafaati, M; Solomon, A; Kivipelto, M; Björkhem, I; Leoni, V
Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease
2007 Valenza, M; Leoni, V; Tarditi, A; Mariotti, C; Björkhem, I; Di Donato, S; Cattaneo, E
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease
2008 Leoni, V; Mariotti, C; Tabrizi, S; Valenza, M; Wild, E; Henley, S; Hobbs, N; Mandelli, M; Grisoli, M; Björkhem, I; Cattaneo, E; Di Donato, S
Oxysterols and neurodegenerative diseases
2009 Björkhem, I; Cedazo-Minguez, A; Leoni, V; Meaney, S
Oxysterols as markers of neurological disease--a review
2009 Leoni, V
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease
2009 Solomon, A; Leoni, V; Kivipelto, M; Besga, A; Oksengård, A; Julin, P; Svensson, L; Wahlund, L; Andreasen, N; Winblad, B; Soininen, H; Björkhem, I
Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes
2010 Valenza, M; Leoni, V; Karasinska, J; Petricca, L; Fan, J; Carroll, J; Pouladi, M; Fossale, E; Nguyen, H; Riess, O; Macdonald, M; Wellington, C; Didonato, S; Hayden, M; Cattaneo, E
Genetic connections between neurological disorders and cholesterol metabolism
2010 Björkhem, I; Leoni, V; Meaney, S
Links between ApoE, brain cholesterol metabolism, tau and amyloid β-peptide in patients with cognitive impairment
2010 Leoni, V; Solomon, A; Kivipelto, M
Cerebral and extracerebral cholesterol biosynthesis is impaired in HD patients
2010 Leoni, V; Mariotti, C; Nanetti, L; Tomasello, C; Salvatore, E; Di Michele, G; Soletti, F; Bentivoglio, A; Bandettini del Poggio, M; Abbruzzese, G; Piacentini, S; Squitieri, F; Valenza, M; Cattaneo, E; Di Donato, S